dr. bendell on a phase ii study of onartuzumab in combination with bevacizumab for mcrc
Published 10 years ago • 189 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
0:32
dkn-01 with bevacizumab and chemotherapy in advanced crc
-
1:30
dr. overman on the combination of atezolizumab and bevacizumab in hcc
-
0:49
dr. bendell discusses a phase iii study of apatinib in gastric cancer
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
1:21
dr. joseph on the combination of atezolizumab and bevacizumab in mrcc
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
0:54
dr cecchini on etrumadenant-based combinations in previously treated mcrc
-
2:42
paradigm: panitumumab versus bevacizumab in ras-wt mcrc
-
6:59
optimizing frontline chemotherapy in metastatic colorectal cancer
-
0:54
dr. bendell discusses pembrolizumab in crc
-
4:03
maintenance treatment in colorectal cancer
-
1:17
dr. balar discusses bevacizumab in bladder cancer
-
5:39
prodige 20: bevacizumab ct vs ct alone in elderly patients with untreated mcrc
-
1:43
dr mouabbi on clinical trials for invasive lobular breast cancer
-
1:20
dr. larson on ongoing trials in colorectal cancer
-
0:31
dr. eng: re-initiating bevacizumab after multiple lines of treatment
-
0:49
dr. bang on pembrolizumab for advanced gastric cancer
-
1:42
dr. overman on the impact of nivolumab in mcrc